NCT04330846

Brief Summary

Stenosis is one of the most frequent complications in patients with Crohn's disease (CD), causing greater morbidity and increasing the probability of repeated surgery and short bowel syndrome (1-3). Endoscopic balloon dilation (EBD) is clearly the treatment of choice for short stenoses located at the anastomosis of previous surgeries (4-6). However, there is no scientific evidence for determining the most appropriate treatment for de novo stenosis less than 10 cm in length (surgical versus endoscopic treatment), both in terms of efficacy and complications. Neither has it been established which of these two approaches has a greater impact on the quality of life of patients and on costs.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Nov 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

16 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Nov 2022Apr 2027

First Submitted

Initial submission to the registry

March 25, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 2, 2020

Completed
2.7 years until next milestone

Study Start

First participant enrolled

November 29, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Expected
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

3.3 years

First QC Date

March 25, 2020

Last Update Submit

August 18, 2025

Conditions

Keywords

crohn

Outcome Measures

Primary Outcomes (1)

  • Quality of life of patients

    Percentage of patients with an increase of more than 30 points in the Inflammatory Bowel Disease Questionnaire (IBDQ-32) quality of life index. The higher the better.

    One year of follow-up

Secondary Outcomes (2)

  • Percentage of patients with clinical recurrence

    One year of follow-up

  • Percentage of complications

    One year of follow-up

Study Arms (2)

EBD group

EXPERIMENTAL

* Post-procedural admission in the Short Stay Unit (SSU). * Superficial sedation by endoscopist or anesthesiologist depending on the center. * Pneumatic balloon type CRE Boston scientific®; diameter of the balloon at the endoscopist's discretion. * A maximum of 2 dilations will be performed with a minimum interval of 15-30 days between each dilation. * Dilation failure will be considered if \> 2 dilations are required.

Procedure: Surgical resection

SEMS group

EXPERIMENTAL

* Post-procedural admission in the Short Stay Unit (SSU). * Superficial sedation by endoscopist or anesthesiologist depending on the center. * Fully coated, self-expanding Tae Woong medical®-type metal prostheses; size of the prostheses at the discretion of the endoscopist * Clips can be placed at the distal end of the prosthesis at the endoscopist's discretion. * Removal time of the prosthesis 4 weeks.

Procedure: Surgical resection

Interventions

The type of endoscopic treatment will be initially with EBD and if a failure treatment occurred then a SEMS will be placed.

EBD groupSEMS group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age.
  • Crohn's disease with predominantly de novo fibrotic stenosis\* confirmed by endoscopic and radiological tests, accessible by endoscopy (colonoscopy).
  • Symptomatology of intestinal occlusion-subocclusion.
  • Refractoriness to conventional medical treatment (non-response to the usual accelerated step-up therapeutic approach).
  • Stenosis length \< 10 cm.
  • Maximum of 2 stenoses.
  • Informed consent from patient.

You may not qualify if:

  • No informed consent from the patient.
  • Complicated stenosis with abscess, fistula or significant activity associated with CD not limited to the area of the stenosis.
  • Pregnancy or lactation.
  • Any clinical situation that prevents the performance of endoscopy or surgery.
  • Stenosis not accessible by endoscopy.
  • Asymptomatic patient.
  • Stenosis length ≥ 10 cm.
  • Presents with \> 2 stenoses.
  • Severe coagulation disorders (platelets \< 70000; INR \> 1.8).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

Hospital Germans Trias i Pujol

Badalona, Barcelona, 08916, Spain

NOT YET RECRUITING

Hospital Universitario de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

NOT YET RECRUITING

Althaia, xarxa assistencial universitaria de Manresa

Manresa, Barcelona, 08243, Spain

NOT YET RECRUITING

Consorci Corporació Sanitària Parc Taulí

Sabadell, Barcelona, 08208, Spain

RECRUITING

Hospital Moisès Broggi

Sant Joan Despí, Barcelona, 08970, Spain

NOT YET RECRUITING

Hospital Mutua de Terrassa

Terrassa, Barcelona, 08221, Spain

RECRUITING

Hospital Universitario de Cáceres

Cáceres, Spain

RECRUITING

Clínica Girona

Girona, Spain

NOT YET RECRUITING

Hospital Josep Trueta

Girona, Spain

NOT YET RECRUITING

Hospital de Inca

Inca, Spain

NOT YET RECRUITING

Hospital Universitari Arnau de Vilanova

Lleida, 25198, Spain

RECRUITING

Hospital Universitario La Paz

Madrid, 28046, Spain

NOT YET RECRUITING

Hospital Universitario Ramon y Cajal

Madrid, Spain

NOT YET RECRUITING

Hospital de Terrassa

Terrassa, Spain

NOT YET RECRUITING

Hospital Clínico de Valencia

Valencia, 46010, Spain

NOT YET RECRUITING

Hospital Universitari La Fe

Valencia, Spain

RECRUITING

Related Publications (19)

  • Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011 May;140(6):1785-94. doi: 10.1053/j.gastro.2011.01.055.

    PMID: 21530745BACKGROUND
  • Solberg IC, Vatn MH, Hoie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I; IBSEN Study Group. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1430-8. doi: 10.1016/j.cgh.2007.09.002.

    PMID: 18054751BACKGROUND
  • Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010 Feb;105(2):289-97. doi: 10.1038/ajg.2009.579. Epub 2009 Oct 27.

    PMID: 19861953BACKGROUND
  • Hassan C, Zullo A, De Francesco V, Ierardi E, Giustini M, Pitidis A, Taggi F, Winn S, Morini S. Systematic review: Endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther. 2007 Dec;26(11-12):1457-64. doi: 10.1111/j.1365-2036.2007.03532.x. Epub 2007 Sep 28.

    PMID: 17903236BACKGROUND
  • Morar PS, Faiz O, Warusavitarne J, Brown S, Cohen R, Hind D, Abercrombie J, Ragunath K, Sanders DS, Arnott I, Wilson G, Bloom S, Arebi N; Crohn's Stricture Study (CroSS) Group. Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn's disease strictures. Aliment Pharmacol Ther. 2015 Nov;42(10):1137-48. doi: 10.1111/apt.13388. Epub 2015 Sep 11.

    PMID: 26358739BACKGROUND
  • Navaneethan U, Lourdusamy V, Njei B, Shen B. Endoscopic balloon dilation in the management of strictures in Crohn's disease: a systematic review and meta-analysis of non-randomized trials. Surg Endosc. 2016 Dec;30(12):5434-5443. doi: 10.1007/s00464-016-4902-1. Epub 2016 Apr 28.

    PMID: 27126619BACKGROUND
  • Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990 Oct;99(4):956-63. doi: 10.1016/0016-5085(90)90613-6.

    PMID: 2394349BACKGROUND
  • Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lemann M, Colombel JF. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol. 2009 Aug;104(8):2089-96. doi: 10.1038/ajg.2009.301. Epub 2009 Jun 30.

    PMID: 19568226BACKGROUND
  • Loras C, Mayor V, Fernandez-Banares F, Esteve M. Study of the standard direct costs of various techniques of advanced endoscopy. Comparison with surgical alternatives. Dig Liver Dis. 2018 Jul;50(7):689-697. doi: 10.1016/j.dld.2018.03.002. Epub 2018 Mar 12.

    PMID: 29610018BACKGROUND
  • Wright EK, Kamm MA. Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review. Inflamm Bowel Dis. 2015 May;21(5):1187-94. doi: 10.1097/MIB.0000000000000271.

    PMID: 25895008BACKGROUND
  • Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ, Sebastian S, Laureti S, Sampietro GM, Vucelic B, van der Woude CJ, Barreiro-de Acosta M, Maaser C, Portela F, Vavricka SR, Gomollon F; ECCO. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. J Crohns Colitis. 2017 Feb;11(2):135-149. doi: 10.1093/ecco-jcc/jjw169. Epub 2016 Sep 22.

    PMID: 27660342BACKGROUND
  • Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G, de Buck van Overstraeten A, Burke JP, Buskens CJ, Colombo F, Dias JA, Eliakim R, Elosua T, Gecim IE, Kolacek S, Kierkus J, Kolho KL, Lefevre JH, Millan M, Panis Y, Pinkney T, Russell RK, Shwaartz C, Vaizey C, Yassin N, D'Hoore A. ECCO-ESCP Consensus on Surgery for Crohn's Disease. J Crohns Colitis. 2018 Jan 5;12(1):1-16. doi: 10.1093/ecco-jcc/jjx061. No abstract available.

    PMID: 28498901BACKGROUND
  • Andujar X, Loras C, Gonzalez B, Socarras M, Sanchiz V, Bosca M, Domenech E, Calafat M, Rodriguez E, Sicilia B, Calvet X, Barrio J, Guardiola J, Iglesias E, Casanova MJ, Ber Y, Monfort D, Lopez-Sanroman A, Rodriguez-Lago I, Bujanda L, Marquez L, Martin-Arranz MD, Zabana Y, Fernandez-Banares F, Esteve M; ENEIDA registry of GETECCU. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry. Surg Endosc. 2020 Mar;34(3):1112-1122. doi: 10.1007/s00464-019-06858-z. Epub 2019 May 29.

    PMID: 31144122BACKGROUND
  • Attar A, Maunoury V, Vahedi K, Vernier-Massouille G, Vida S, Bulois P, Colombel JF, Bouhnik Y; GETAID. Safety and efficacy of extractible self-expandable metal stents in the treatment of Crohn's disease intestinal strictures: a prospective pilot study. Inflamm Bowel Dis. 2012 Oct;18(10):1849-54. doi: 10.1002/ibd.22844. Epub 2011 Dec 11.

    PMID: 22161935BACKGROUND
  • Levine RA, Wasvary H, Kadro O. Endoprosthetic management of refractory ileocolonic anastomotic strictures after resection for Crohn's disease: report of nine-year follow-up and review of the literature. Inflamm Bowel Dis. 2012 Mar;18(3):506-12. doi: 10.1002/ibd.21739. Epub 2011 May 3.

    PMID: 21542067BACKGROUND
  • Loras C, Perez-Roldan F, Gornals JB, Barrio J, Igea F, Gonzalez-Huix F, Gonzalez-Carro P, Perez-Miranda M, Espinos JC, Fernandez-Banares F, Esteve M. Endoscopic treatment with self-expanding metal stents for Crohn's disease strictures. Aliment Pharmacol Ther. 2012 Nov;36(9):833-9. doi: 10.1111/apt.12039.

    PMID: 22966851BACKGROUND
  • Loras Alastruey C, Andujar Murcia X, Esteve Comas M. The role of stents in the treatment of Crohn's disease strictures. Endosc Int Open. 2016 Mar;4(3):E301-8. doi: 10.1055/s-0042-101786.

    PMID: 27014743BACKGROUND
  • Multicenter prospective randomized study to compare endoscopic treatment of strictures in crohn´s disease: self-expanding metal stents vs endoscopic balloon dilation. Protdilat study. Andujar X, Loras Alastruey C, Gornals J.B, Guardiola J., Sanchiz V., Bosca M., Brullet E., Sicília Aladrén B., Naranjo Rodríguez A., Martín-Arranz M.D., Dueñas-Sadornil C., Foruny J.R., Barrio Andrés J., Monfort Miquel D., Busquets Casals D., Pineda J.R., Pérez-Roldán F., Pons Beltrán V., González-Huix Lladó F., Sainz E., Gonzalez B.9,, Reyes Moreno J., Fernández-Bañares F.9,, Esteve M. 27rd United European Gastroenterology Week (UEGW). Barcelona 2019. UNITED EUROPEAN GASTROENTEROLOGY Barcelona 22- 24 October 2019.

    BACKGROUND
  • Loras C, Ruiz-Ramirez P, Romero J, Andujar X, Bargallo J, Bernardos E, Bosca-Watts MM, Brugiotti C, Brunet E, Busquets D, Cerrillo E, Cortina FJ, Diaz-Milanes JA, Duenas C, Farres R, Golda T, Gonzalez-Huix F, Gornals JB, Guardiola J, Julia D, Lira A, Llao J, Manosa M, Marin I, Millan M, Monfort D, Moro D, Mullerat J, Navarro M, Perez Roldan F, Pijoan E, Pons V, Reyes J, Rufas M, Sainz E, Sanchiz V, Serracant A, Sese E, Soto C, Troya J, Zaragoza N, Tebe C, Paraira M, Sudria-Lopez E, Mayor V, Fernandez-Banares F, Esteve M; Grupo Espanol de Trabajo de la Enfermedad de Crohn y Colitis Ulcerosa GETECCU. Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial. Trials. 2023 Jun 27;24(1):432. doi: 10.1186/s13063-023-07447-1.

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Officials

  • Carme Loras

    Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: A prospective multicenter randomized comparative study of the treatment of de novo stenosis due to CD, comparing endoscopic treatment (stent or EBD) vs. surgical resection (SR). The type of endoscopic treatment will be initially with EBD and if a failure treatment occurred then a SEMS will be placed.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2020

First Posted

April 2, 2020

Study Start

November 29, 2022

Primary Completion

April 1, 2026

Study Completion (Estimated)

April 1, 2027

Last Updated

August 19, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations